JP2009500310A - 長時間作用性のベータ作用薬と少なくとも1種の更なる有効成分とを含む呼吸器系疾患治療用の新規な医薬組成物 - Google Patents

長時間作用性のベータ作用薬と少なくとも1種の更なる有効成分とを含む呼吸器系疾患治療用の新規な医薬組成物 Download PDF

Info

Publication number
JP2009500310A
JP2009500310A JP2008518835A JP2008518835A JP2009500310A JP 2009500310 A JP2009500310 A JP 2009500310A JP 2008518835 A JP2008518835 A JP 2008518835A JP 2008518835 A JP2008518835 A JP 2008518835A JP 2009500310 A JP2009500310 A JP 2009500310A
Authority
JP
Japan
Prior art keywords
amino
quinazoline
phenyl
methoxy
chloro
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2008518835A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009500310A5 (cg-RX-API-DMAC7.html
Inventor
インゴ コネツキー
ティエリー ブーイスー
ザビーネ ペシュテル
アンドレアス シュナップ
Original Assignee
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング filed Critical ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング
Publication of JP2009500310A publication Critical patent/JP2009500310A/ja
Publication of JP2009500310A5 publication Critical patent/JP2009500310A5/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/538—1,4-Oxazines, e.g. morpholine ortho- or peri-condensed with carbocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/06—Antiabortive agents; Labour repressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Reproductive Health (AREA)
  • Pain & Pain Management (AREA)
  • Dermatology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Immunology (AREA)
  • Endocrinology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
JP2008518835A 2005-07-01 2006-06-28 長時間作用性のベータ作用薬と少なくとも1種の更なる有効成分とを含む呼吸器系疾患治療用の新規な医薬組成物 Pending JP2009500310A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102005030733A DE102005030733A1 (de) 2005-07-01 2005-07-01 Neue Arzneimittelkombinationen zur Behandlung von Atemwegserkrankungen enthaltend langwirksame Beta-2-Agonisten und wenigstens einen weiteren Wirkstoff
PCT/EP2006/063650 WO2007003554A1 (de) 2005-07-01 2006-06-28 Neue arzneimittelkombinationen zur behandlung von atemwegserkrankungen enthaltend langwirksame beta-2-agonisten und wenigstens einen weiteren wirkstoff

Publications (2)

Publication Number Publication Date
JP2009500310A true JP2009500310A (ja) 2009-01-08
JP2009500310A5 JP2009500310A5 (cg-RX-API-DMAC7.html) 2009-08-13

Family

ID=37087177

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008518835A Pending JP2009500310A (ja) 2005-07-01 2006-06-28 長時間作用性のベータ作用薬と少なくとも1種の更なる有効成分とを含む呼吸器系疾患治療用の新規な医薬組成物

Country Status (9)

Country Link
US (1) US20070037781A1 (cg-RX-API-DMAC7.html)
EP (1) EP1901776B1 (cg-RX-API-DMAC7.html)
JP (1) JP2009500310A (cg-RX-API-DMAC7.html)
AR (1) AR054810A1 (cg-RX-API-DMAC7.html)
AT (1) ATE546159T1 (cg-RX-API-DMAC7.html)
CA (1) CA2613828A1 (cg-RX-API-DMAC7.html)
DE (1) DE102005030733A1 (cg-RX-API-DMAC7.html)
TW (1) TW200740440A (cg-RX-API-DMAC7.html)
WO (1) WO2007003554A1 (cg-RX-API-DMAC7.html)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2017516812A (ja) * 2014-06-02 2017-06-22 メディシノバ・インコーポレイテッドMediciNova, Inc. 線維症の抑制又は治療方法
JP2020059703A (ja) * 2018-10-03 2020-04-16 エーブイエム・バイオテクノロジー・エルエルシー 免疫除去療法

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060035893A1 (en) * 2004-08-07 2006-02-16 Boehringer Ingelheim International Gmbh Pharmaceutical compositions for treatment of respiratory and gastrointestinal disorders
WO2010054285A2 (en) * 2008-11-10 2010-05-14 National Health Research Institutes Fused bicyclic and tricyclic pyrimidine compounds as tyrosine kinase inhibitors
JP2014532063A (ja) * 2011-10-12 2014-12-04 テリジェン リミテッドTeligene Ltd キナーゼ阻害剤としてのキナゾリン誘導体およびその使用方法
EP3413976A1 (en) * 2016-02-08 2018-12-19 Redx Pharma PLC Heterocyclic compounds, in particular 2-oxo-4,4,5,5,6,6,7,7-octahydrobenzoxazole derivatives, and their use as antibacterial compounds

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS52108970A (en) * 1976-03-09 1977-09-12 Boehringer Sohn Ingelheim Production of novel aminoalkyl heterocyclic compound

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4570630A (en) * 1983-08-03 1986-02-18 Miles Laboratories, Inc. Medicament inhalation device
AU591152B2 (en) 1985-07-30 1989-11-30 Glaxo Group Limited Devices for administering medicaments to patients
SE453566B (sv) 1986-03-07 1988-02-15 Draco Ab Anordning vid pulverinhalatorer
SG45171A1 (en) 1990-03-21 1998-01-16 Boehringer Ingelheim Int Atomising devices and methods
DE4318455A1 (de) 1993-06-03 1994-12-08 Boehringer Ingelheim Kg Kapselhalterung
DE19536902A1 (de) 1995-10-04 1997-04-10 Boehringer Ingelheim Int Vorrichtung zur Hochdruckerzeugung in einem Fluid in Miniaturausführung
CA2341488A1 (en) * 1998-08-26 2000-03-09 Smithkline Beecham Corporation Therapies for treating pulmonary diseases
AU2002214996B2 (en) 2000-10-12 2007-03-15 Boehringer Ingelheim Pharma Gmbh & Co. Kg Crystalline monohydrate, method for producing the same and the use thereof in the production of a medicament
DE10050994A1 (de) 2000-10-14 2002-04-18 Boehringer Ingelheim Pharma Neue als Arneimittel einsetzbare Anticholinergika sowie Verfahren zu deren Herstellung
DE10050995A1 (de) 2000-10-14 2002-04-18 Boehringer Ingelheim Pharma Neue Anticholinergika, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel
CA2450961C (en) 2001-06-22 2010-03-30 Boehringer Ingelheim Pharma Gmbh & Co. Kg Crystalline anticholinergic, processes for preparing it and its use for preparing a pharmaceutical composition
DE10203749A1 (de) 2002-01-31 2003-08-14 Boehringer Ingelheim Pharma Neue Anticholinergika, Verfahren zu deren Herstellung sowie deren Verwendung als Arzneimittel
DE10203741A1 (de) 2002-01-31 2003-08-14 Boehringer Ingelheim Pharma Neue Fluorencarbonsäureester, Verfahren zu deren Herstellung sowie deren Verwendung als Arzneimittel
DE10203753A1 (de) 2002-01-31 2003-08-14 Boehringer Ingelheim Pharma Neue Xanthencarbonsäureester, Verfahren zu deren Herstellung sowie deren Verwendung als Arzneimittel
DE10246374A1 (de) * 2002-10-04 2004-04-15 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Betamimetika mit verlängerter Wirkungsdauer, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel
US7056916B2 (en) * 2002-11-15 2006-06-06 Boehringer Ingelheim Pharma Gmbh & Co. Kg Medicaments for the treatment of chronic obstructive pulmonary disease
DE10253282A1 (de) * 2002-11-15 2004-05-27 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Arzneimittel zur Behandlung von chronisch obstruktiver Lungenerkrankung
DK1567139T3 (da) * 2002-11-27 2008-11-03 Nycomed Gmbh Hidtil ukendt synergistisk kombination der omfatter roflumilast og formoterol
WO2005013994A1 (en) * 2003-07-31 2005-02-17 Boehringer Ingelheim International Gmbh Medicaments for inhalation comprising anticholinergics and a betamimetic
CA2534693A1 (en) * 2003-08-05 2005-02-17 Boehringer Ingelheim International Gmbh Medicaments for inhalation comprising steroids and a betamimetic
DE102004003428A1 (de) * 2004-01-23 2005-08-11 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue langwirksame Beta-2-Agonisten, und deren Verwendung als Arzneimittel

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS52108970A (en) * 1976-03-09 1977-09-12 Boehringer Sohn Ingelheim Production of novel aminoalkyl heterocyclic compound

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
JPN6012010810; WONG,W.S.: 'Inhibitors of the tyrosine kinase signaling cascade for asthma' Curr Opin Pharmacol Vol.5, No.3, 200506, p.264-71 *
JPN7012000756; CURRIE,G.P. et al: 'Therapeutic modulation of allergic airways disease with leukotriene receptor antagonists' QJM Vol.98, No.3, 200503, p.171-82 *
JPN7012000757; CALHOUN,W.J.: 'Management of respiratory failure. The rising problems of asthma; mechanisms and management' Chest Vol.101, No.6 Suppl, 1992, p.410S-414S *
JPN7012000759; LAGENTE,V. et al: 'Selective PDE4 inhibitors as potent anti-inflammatory drugs for the treatment of airway diseases' Mem Inst Oswaldo Cruz Vol.100 Suppl 1, 200503, p.131-6 *

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2017516812A (ja) * 2014-06-02 2017-06-22 メディシノバ・インコーポレイテッドMediciNova, Inc. 線維症の抑制又は治療方法
JP2020059703A (ja) * 2018-10-03 2020-04-16 エーブイエム・バイオテクノロジー・エルエルシー 免疫除去療法
JP7671125B2 (ja) 2018-10-03 2025-05-01 エーブイエム・バイオテクノロジー・エルエルシー 免疫除去療法

Also Published As

Publication number Publication date
EP1901776A1 (de) 2008-03-26
DE102005030733A1 (de) 2007-01-04
ATE546159T1 (de) 2012-03-15
WO2007003554A1 (de) 2007-01-11
TW200740440A (en) 2007-11-01
EP1901776B1 (de) 2012-02-22
US20070037781A1 (en) 2007-02-15
CA2613828A1 (en) 2007-01-11
AR054810A1 (es) 2007-07-18

Similar Documents

Publication Publication Date Title
US20050239778A1 (en) Novel medicament combinations for the treatment of respiratory diseases
DE102004019540A1 (de) Neue Arzneimittelkombinationen zur Behandlung von Atemwegserkrankungen
CA2559699C (en) Pharmaceutical combinations containing benzoxazine for treating respiratory diseases
JP2007537196A (ja) 新規の鏡像異性的に純粋なベータ−作用薬、その製造方法および製剤の形体におけるその使用
JP2010501521A (ja) 呼吸器疾患治療用医薬組成物
CN102781916B (zh) 作为缓激肽b1拮抗剂的化合物
EP1901776B1 (de) Neue arzneimittelkombinationen zur behandlung von atemwegserkrankungen enthaltend langwirksame beta-2-agonisten und wenigstens einen weiteren wirkstoff
US20100297028A1 (en) Medicament combinations for the treatment of respiratory diseases
EP2051714B1 (de) Arzneimittelkombinationen zur behandlung von atemwegserkrankungen
DE102004052987A1 (de) Neue Arzneimittelkombinationen zur Behandlung von Atemwegserkrankungen
HK1134018A (en) Drug combinations for treating airway diseases
MXPA06011721A (en) Pharmaceutical combinations containing benzoxazine for treating respiratory diseases

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20090629

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20090629

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20120305

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20120605

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20120717

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20121210